Summary. The admission data and the course of 58 episodes of severe diabetic ketoacidotic coma and of 28 episodes of non-ketotic coma are compared. The non-ketotic patients were older; initial blood glucose, osmolarity, blood urea and serum sodium concentration were higher than in the ketotic patients. Treatment in the first 24 hrs consisted of similar amounts of insulin in both coma forms, the presence of acidaemia did not increase the insulin needs. Acidaemia was corrected only when pH was below 7.20. The disadvantages of alkali therapy are emphasized. A comparison of the age groups of survivors and those patients who died within 72 hrs showed an increase in mortality with age. However, the mortality rates from ketotic and non-ketotic coma were similar in the age groups above 50 years. On admission, blood glucose, osmolarity and blood urea were higher in the fatal cases. Blood urea was the most important indicator of a fatal outcome. The response of blood glucose to insulin was impaired in the subsequently fatal cases. Insulin was given in "moderate" doses by constant infusion. The use of "small" doses is discussed. Early mortality was 14Yo in the ketotic and 29~o in the non-ketotic cases. The most frequent causes of death were circulatory failure of undetermined origin, infections and ~hromboembolic complications.
According to recent epidemiological studies diabetic coma occurs in 3 of 1,000 diabetics per year (Panzram, 1) . The indicence will obviously depend on the proper education of both, doctor and patient. However, as the same author has pointed out, about 1/a of the cases were in patients not known previously to be diabetic, so that a certain incidence will always be maintained.
Diabetic coma is associated with a high mortality. We introduced in 1968 a schedule of treatment [2] which we hoped would be of benefit to hospital physicians for the rapid and safe correction of the metabolic disorder.
Therapeutic measures should include the immediate administration of insulin and the correction of fluid and electrolyte deficits although the amounts of the single components and their rate of administration remain controversial [3, 4] .
The following study was performed first to prove the value of an easily manageable schedule of treatment; second, to provide a schedule for use in the treatment of both ketotic and non-ketotic hyperosmolar coma and to compare the course and features of these two syndromes, and third, to delineate useful prognostic factors for morbidity and mortality.
Previous observations on mortality of diabetic coma include cases of minor severity and treatment is not attempted according to a prospective program. Therefore, the risk factors for mortality are evaluated in patients with severe precoma and coma under comparable therapy.
Material and Methods
The case records of 58 consecutive episodes of ketotic and 28 episodes of non-ketotic coma in 75 patients were analyzed. All patients were treated in the Intensive Care Unit (ICU) of the Medical Clinic, University Hospital, Basle, in the years 1968--1973.
The depth of coma was evaluated in each case on admission and 12 hrs after onset of therapy. The patients were allocated into 3 grades of unconsciousness. Patients in grade 1 on admission were awake and fully responsive, they were excluded from the study. Grade 2 included patients who reacted to external stimuli, they were not able to give adequate response s. Patients in grade 3 were comatose, voluntary motions upon external stimulation were absent.
Allocation to the group with ketoacidotic coma depended on a positive plasma acetone test [5] , on the presence of acidaemia (pHi7. 30) and on elevated blood glucose (> 350 mg/100 ml). Non-ketotic hyperosmolar coma was said to be present when Diabetologia, Vol. 11 7 plasma osmolality was greater than 330 mOsm/kg with a blood glucose concentration greater than 500 mg/100 ml and a negative plasma acetone test. Osmolality was calculated according to the formula: mOsm/kg = 2 (Na -1-K) (mEq/1) § glucose (rag/100 ml) urea (mg/100 ml) 18 q-6
A semiquantitative guide to blood glucose and ketone body concentrations was obtained in the emergency room by using test strips (Tes Tape | and Ketostix | on tear fluid [6] . This allowed early diagnosis and the immediate onset of treatment. The first insulin dose (10--50 U) of regular insulin was given intravenously or intramuscularily according to the estimated or known blood glucose. Insulin was then administered by constant infusion. The rate of insulin infusion depended on the concentration of blood glucose and on the result of the plasma acetone test. 20--140 U per 2 hrs of insulin were administered in the presence of ketoacidosis and 10--100 U per 2 hrs in non-ketotic cases. Potassium therapy was begun only after knowledge of serum potassium. The amount of intravenous fluid was judged by the central venous pressure (CVP); the type of fluid depended on the serum sodium concentration. Acidaemia was corrected by sodium bicarbonate only when pH was below 7.20. The amount of bicarbonate given was calculated according to the formula: mEq= 0.1 • Base Excess (BE) • Body wt. (kg). Subsequent treatment with insulin, sodium, potassium and fluids was adjusted at two-hourly intervals according to the resuits of biochemical monitoring. The dose of insulin depended on the rate of fall of blood glucose; on the basis of this the dose of the first infusion was repeated or reduced to as little as 1/8. The details of the schedule of treatment have been published previously [2, 61 . Fatalities were divided into early (less than 72 hrs) and late deaths (after 72 hrs). In the following results the survivors and the early deaths are compared.
Students t-test and the ~2-test were used for statistical analysis. All data are indicated as means + S.D.
Results

Admission Data
Age and Sex ( Table 1 ). The mean age on admission was significantly higher for the cases with nonketotic coma (range 49--87 years) as compared to those with ketotic coma (range 19--84 years).
A comparison of deaths with age showed the fatal cases to be older than non-fatal cases, the difference was statistically significant. Mortality rates in the various age groups are shown in Table 2 , the most significant finding being that only one death occurred under the age of 50. The mortality rates of both forms of coma were similar in the decades from 50--89 years.
The distribution of sex indicates a higher prevalence of diabetic coma in females, whereas mortality rate was greater in males. Laboratory Values on Admission. Non-ketotic coma was associated with significantly higher values of initial blood urea, osmolality and sodium in comparison with the ketotic cases ( Table 3 ). Blood glucose was similar in both groups. The increased sodium and osmolality in the non-ketotic cases suggests a predominant deficit of free water in these cases.
Serum creatinine was erroneously high in ketoacidotic patients because acetoaeetate interfered with creatinine measurement in our laboratory technique
[8].
Blood urea, osmolality and blood glucose were significantly elevated in patients who subsequently died. Sodium and potassium concentration were similar in both groups. Since a high blood urea and osmolality were both associated with a high mortality, we tried to elucidate the differential contribution of these two interrelated factors ( Table 4) . As a result of this analysis it appeared that a raised blood urea was associated with a high mortality irrespective of serum osmolality.
One can therefore postulate that the degree of depletion was the same in the two groups of patients. However, more rapid administration was necessary in the initial period in the ketotic patients reflecting no doubt the effects of correction of acidaemia. In non-ketotic coma, the hourly potassium administration did not exceed 50 mEq per hour, whereas in ketotic patients amounts of 60--100 mEq per hour were sometimes needed to correct hypokalemia.
Both groups of patients were given similar amounts 
Treatment in the First 24 Hours (Table 5)
On average the ketotic patients were given slightly more insulin than the non-ketotic cases, but the difference was not significant.
The amount of potassium required in the first 24 hrs was similar in the ketotic and non-ketotic cases. of fluid but the non-ketotic patients retained significantly more fluid, and were also given significantly less sodium. The latter reflects the practice of administrating hypotonic fluids to the non-ketotic patients.
Obviously ketotic patients received more bicarbonate than the non-ketotic group. Lactic acidaemia 7* (pH<7.25) was found to be present in 2 (10Yo) of the surviving andin 6 (75Yo) of the dying non-ketotic patients. This required rigorous alkali therapy which explains why the non-ketotic groups as a whole was given considerable amounts of bicarbonate.
When the treatment of the survivors and the nonsurvivors is compared, the amount of insulin given was the only parameter with a significant difference. Seven patients with a survival time of less than 24 hrs were excluded from the calculation. Less potassium and more bicarbonate was administered to the patients who died because of the frequent incidence of shock. each instance, and no patient was lost from hypokalemia. Increased serum potassium (>6.0 mgq/1) was seen in 6 (37Yo) of the dying patients. In these cases hyperkalemia was associated with shock or anuria.
The central venous pressure (CVP) on admission showed a broad range from --2 to 15 cm H~O. The average minimal CVP observed during the first 24 hours was lower in the ketotic than in the non-ketotic cases (Table 6 ). It is particularly noteworthy that maximal and minimal CVP readings were significantly greater in the fatal cases compared with the survivors. Hypotensive episodes in the first 24 hours Blood glucose fell below 300 mg/100 ml after a mean duration of 8.7 hrs in the ketotic cases as compared to 10.3 hrs in the non-ketotic patients. Blood glucose values below 80 mg/!00 ml were present in 11 (19~o) of the ketotic cases after a mean interval of 17 hrs, whereas no decline below this level occurred in the non-ketotic patients. Therefore, in ketotic coma insulin sensitivity is rapidly restored.
The decline of blood glucose was significantly slower in dying patients compared with survivors.
Hypokalemia (<3.0 mEq/1) was observed in 18 (23Yo) of all patients after a mean duration of 4.9 hrs. Rapid correction of serum potassium was possible in were observed in 28 cases. The occurence of hypotension was an ominous sign, 14 (93Yo) of the nonsurvivors compared to 14 (21Yo) of the survivors were hypotensive or were in established shock. This explains the occurence of lower urine outputs in the fatal cases.
Consciousness. The degree of unconsciousness was evaluated in each case on admission and 12 hrs after onset of treatment. On admission, 33 of the cases were classified as grade 2 representing the group of "pre" coma, whereas 52 patients were in grade 3, they were in deep coma. The depth of coma on admission did not correlate with either the extent of the acidaemia or mortality. In contrast, there was a marked correlation between the impairment of consciousness 12 hrs after admission and subsequent outcome (Table  7) . Prolonged coma was typical of the fatal cases while non-ketotic patients recovered more slowly than ketotic ones.
Pathologic Findings in the Deaths
The mortality rates in the ketotic and in the nonketotic cases are summarized in Table 8 . Two thirds of the deaths occurred within 3 days, one third later during the same hospitalisation. The mortality rate of non-ketotic coma seemed to be higher than that of ketotic coma. , Table 9 describes the causes of the early and of the late deaths. Postmortem examination was performed in all cases except one (cause of death unknown). In 7 cases of early death the fatal outcome was attributed to severe diabetic coma. In 6 of them final diagnosis was circulatory failure. In each case, chronic heart disease was found (ischaemic heart disease in 5, hypertensive heart disease in one). Their course was characterized by protracted hypotension despite adequate fluid therapy. In one case severe brain edema was diagnosed (brain weight 1590 g); however, this patient underwent open cardiac massage for a prolonged period of time. The case was associated with severe ketoacidosis.
The eight cases of late death occurred 6--65 days following recovery from coma. In most of them chronic illnesses with no relation to the preceding coma was the cause of death. Therefore it ~ seems to be justified to ascribe mortality of diabetic coma to a limited interval after onset of treatment.
Discussion
Each case of diabetic coma is an emergency situation which requires rapid and adequate treatment [11] . Since mortality is still high and since one third of the patients of our and of reported series [12, 13] died as a consequence of the metabolic derangement, improved treatment should ameliorate the prognosis of diabetic coma.
Controversy surrounds the administration of insulin. Our patients received amounts in the first 24 hrs similar to those reported elsewhere (review in 14). In a recent publication Alberfi et al. [3] renewed the discussion about the optimal insulin therapy in proposing an intramuscular regimen of low doses of insulin. Further studies [15, 16, 17 ] advocated the administration of similar doses by constant infusion. These results are in accord with previous studies [18] that in the majority of cases smaller doses than generally recommended [14] are effective as large doses. It is possible that in many cases an unsatisfactory hypoglycaemic response to insulin cannot be overcome by increasing the insulin dose, and the restoration of sensitivity to insulin is the conditio sine qua non for the blood glucose lowering effect of insulin.
However, the average degree of severity of these reported "coma" patients was less than that of our cases when the initial blood glucose and the degree of coma are compared. In our fatal episodes blood glucose fell significantly slower than in the surviving patients in spite of the larger amounts of insulin given. Thus, the capability of insulin to lower blood glucose was impaired and the insulin requirements in those who died may have been higher. In clinical practice it is impossible to predict the response to a certain amount of insulin in a coma patient, and it may be that "small" insulin doses aimed at producing serum insulin concentrations that saturate insulin receptors, are sometimes too low. Therefore, we consider it not yet advisable to recommend generally the use of "small" doses because they may fail to meet the insulin requirements of an individual patient.
As to the way of administration, we continue to give insulin by constant infusion. By this route, treatment is easier to control, and the risk of late hypoglycemia should be less than with intramuscular therapy. Furthermore, we do not know in the severe cases with circulatory problems if adsorption of insulin at the injection site is adequate. In contrast to the finding of S/Snksen [19] who examined minimal amounts of insulin, the absorption of currently used amounts of insulin to glass and plastic tubes should not be of major importance for the patient [15, 20] .
The observation that non-ketotic patients seemed to need similar amounts of insulin to the ketotic cases confirms previous statements [21, 22] that insulin sensitivity was rapidly restored after initiation of therapy. The same statement can be made on the patients reported by Walker [24] . He demonstrated that in the initial period of acidaemia the hypoglycaemic effect of insulin was impaired, but his interpretion that impaired insulin action was caused by acidaemia is not conclusive.
The recovery of insulin sensitivity which is more rapid in ketotic cases leads to a rapid decline of blood glucose. This emphasizes the need for frequent monitoring of blood glucose and for changing intravenous therapy to a glucose infusion when blood glucose falls below 300 rag/100 ml.
Potassium supplementation requires close attention since rapid changes of serum potassium are the rule. Hypokalernia occurred as frequently as hyperkalemia, therefore, the application of the schedule roughly guaranteed the correct estimation of the potassium needs. Hypokalemia developed in most cases in the early hours of treatment, therefore insulin and alkali treatment without rapid institution of potassium supply is hazardous. Potassium supply should be curtailed in the absence of good urine output.
The amount of potassium required to correct hypokalemia was in keeping with previous reports [4, 9] that patients with diabetic coma often are in a state of potassium depletion previously underestimated. It demonstrates that earlier recommendations [10, 25] regarding limited potassium repletion are hazardous. According to recent studies the risk of hypokalemia should be attenuated by the use of "small" doses of insulin [3, 15, 17] .
Since hypotension and oliguria were a frequent complication, the monitoring of CVP was a prerequisite for adequate fluid therapy. By this way, liberal amounts of fluid were given. Subsequent complications such as peripheral or pulmonary edema were not observed. Hypotension should primarily be treated with fluid, since fluid deficit is its major cause. The administration of plasma should be limited to cases who fail to respond to fluid therapy. The observation that protracted hypotension in the fatal cases was associated with raised CVP-readings infers that the problem was primarily one of depressed cardiac activity. Protracted renal failure is a known complication of hypotension in diabetic coma [26] , and it was felt that absence of such cases was due to the vigorous fluid administration. The sodium concentration in the infused fluids was adjusted according to the serum sodium. Through this means the separate appraisal of sodium and water needs of ketotic and non-ketotic coma was satisfied.
The institution of therapy leads to shifts of water into the cells, therefore serum sodium concentration tends to rise. In cases where serum sodium is above 145 mEq/1 we recommend the use of hypotonic solutions.
In the light of recent studies concerning alkali therapy in metabolic acidaemia [27] the question arose as to whether alkalinisation has unfavorable effects mediated by a leftshift of the oxyhemoglobin dissociation curve (Bohr effect). In diabetic acidaemia this effect is of special importance because of marked and prolonged decrease of red blood cell 2, 3 -disphosphoglycerate [28] . This causes an increase in oxygen affinity of hemoglobin which may lead to tissue hypoxia. Further unfavorable effects of alkali therapy are the subsequent potassium shifts into the cells which augments the risk of hypokalemia, and the decrease of the venular tone following alkalinization [29] . This latter effect may be responsible for the clinical observation of a decrease of CVP and blood pressure after onset of treatment of diabetic acidaemia. However, treatment of metabolic acidaemia is considered to be mandatory because severe acidaemia impairs cardiac function [30] . Alkali therapy is indicated only when pH falls below a critical level (e.g. 7, 10) .
The evaluation of the risk factors of diabetic coma indicated that elevation of blood urea, osmolality and blood glucose on admission were associated with fatality. Similar observations have been made before [11, 13, 31] . In addition, our data demonstrate that initial blood urea was the most important prognostic factor. An evaluation of blood urea versus osmolality indicated that osmolality per se was not associated with mortality. The increased level of blood urea may be due to increased production and to lowered renal elimination of urea. Thus it reflects the amount and duration of catabolism and the impairment of renal function brought about by dehydration and increased blood viscosity [32] . The mean age of the patients who died was significantly higher than that of the survivors, however, the mortality rates of both coma forms in the age groups above 50 years were similar. Hence it is concluded that prognosis of diabetic coma is not worse in extreme old age than in late middle age, therefore, intensive treatment should be stressed even in elderly patients.
Other factors associated with mortality were prolonged duration of coma and circulatory failure. As previously reported [12, 13] , a large number of patients who died subsequent to diabetic coma were in cardiac failure resistant to therapy.
Associated conditions were present in the majority of cases the most frequent being infection. As a precipitating factor of diabetic coma early recognition and treatment of infection is important. Furthermore, the course of treatment is aggravated by the presence of infection. Blood glucose tends to fall more slowly in these cases [3] since anti-insulin hormones such as glucagon are higher in infected than non-infected cases [33] .
Complications with thromboembolic disorders were responsible for 1/, of our fatalities. In a recent report on fatal diabetic ketoacidosis [34] cerebral intravascular coagulation was implicated as cause of death. One should at least consider the use of prophylactic anticoagnlants. However, in view of the high incidence of erosive gastritis and gastrointestinal bleeding early prophylactic anticoagulation is probably contraindicated.
The development of brain edema seemed to be of minor importance as cause of death. This confirms the statement of Beigelman [13] that it is not justified to accuse aggressive treatment for this fatal complication [36] .
Our mortality rates are higher than that of other reports [11, 12, 35] , however, only severe cases have been studied. They demonstrate that the metabolic derangement and the complications of diabetic coma are still a challenge to any practicing physician.
